UNSPSC 51121911: Gitoformate or pentaformylgitoxin

This classification denotes a digitalis glycoside and digoxin analog with the molecular formula C46H64O19, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier B69U29O7J9, chemically known as gitoxin, pentaformate but generally known as gitoformate, which bears US NIH Compound Identifier 65598. European Medicines Agency schedules Gitoformate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13968MIG. World Health Organization schedules gitoformate in its Anatomical Therapeutic Chemical (ATC) Classification.

GITOFORMATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: OC12C3C(C4(C(CC3)CC(OC3OC(C(OC5OC(C(OC6OC(C(OC=O)C(OC=O)C6)C)C(OC=O)C5)C)C(OC=O)C3)C)CC4)C)CCC1(C(C(OC=O)C2)C1=CC(=O)OC1)C.

UNSPSC 51121911 Gitoformate or pentaformylgitoxin is a Commodity code under which state and local governments procure emergency medical and pharmaceutical products, though recent activity shows the code tagged to broader advanced life support medications and generic multi-source pharmaceutical programs rather than this specific cardiac glycoside formulation. The Tampa Fire Rescue solicitation (City of Tampa, IFB 26P00188, due April 8, 2026) exemplifies the actual work: sealed competitive bidding for specific medication line items including epinephrine, adenosine, labetalol, and diltiazem in precise unit quantities with firm pricing, nine-month minimum expiration guarantees, ten-day delivery, and one-year contract terms with renewal options. Issuing bodies include municipal fire departments and health agencies (Tampa Fire Rescue through the City of Tampa Purchasing Department) and state-level pharmacy benefit programs (Texas Health and Human Services Commission, Minnesota Department of Administration via the Minnesota Multistate Cooperative Purchasing Alliance). The code sees solicitation activity from city procurement offices managing fire and rescue inventories, state HHS agencies overseeing pharmaceutical distribution, and multi-state cooperative purchasing vehicles.

Recent activity concentrates in Florida and the Upper Midwest, with the Tampa Fire Rescue bid in Hillsborough County and the Minnesota Multistate Cooperative Purchasing Alliance RFP (due March 26, 2026) covering participating jurisdictions across Minnesota and Oregon. The Texas HHS RFI (posted April 3, 2026) on direct-to-manufacturer prescriptions signals state-level interest in restructuring pharmaceutical procurement channels outside traditional PBM and wholesaler models, though that solicitation carries no award value or formal evaluation timeline at the information-gathering stage. The MMCAP cooperative (RFP S1070000015802) requires vendors to provide generic pharmaceuticals through three authorized wholesalers (AmerisourceBergen, Cardinal Health, Morris & Dickson) with pricing weighted 75 percent on competitiveness, compliance with cGMP and DSCSA, and insurance requirements ($5 million general liability, $2 million network security liability, $2 million professional liability). Tampa's estimated contract value is $40,000 with a 5 percent SLBE bid discount available; MMCAP pricing models vary (flat price, net price formats, WAC-minus) with a mandatory 3 percent administrative fee and performance penalties of $200 to $1,500 per violation.